glp-1 semaglutide weight loss treatments orem Another Weight-Loss Trial Win for Weekly Drug When Does Semaglutide GLP-1 Start

Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: a global retrospective cohort study

American College of Cardiology Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with T2D and Atherosclerotic Cardiovascular Disease In 2018, the American College of Cardiology (ACC) published an expert consensus decision pathway on the use of novel therapies, namely GLP-1 RAs and SGLT-2 inhibitors, to reduce cardiovascular risk in patients with T2D

Diabetic eye screening: programme overview

The success with GLP-1 drugs has also prompted researchers to start investigating in detail the physiology of GLP-1 in the gut and the brain

BiomeSync Core (20 mg) Inulin (Prebiotic Fiber) Feeds beneficial gut bacteria and supports digestive regularity and satiety